retatrutide type 2 diabetes phase 2 results weight loss trial Retatrutide in Canada: Clinical Results, Cost Expectations, and Patient Experience Retatrutide as a Novel Treatment

Goutzourelas N et al

Now, McDonald and collaborators are actively working to stand up a multisite clinical trial to assess whether GLP-1 medications can lower breast cancer incidence among women at high-risk, including those with a history of breast cancer

Such atypical cells are the dominant component in malignant cellular blue nevus but in contrast comprise only a small component of the cellular blue nevus with atypia

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog PMID: 15817669 Endocrinology